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ABSTRACT The immune system in mammals is composed of multiple different 
immune cell types that migrate through the body and are made continuously through-
out life. Lymphocytes and myeloid cells interact with each other and depend upon 
each other, but each are highly diverse and specialized for different roles. Lymphocytes 
uniquely require developmentally programmed mutational changes in the genome it-
self for their maturation. Despite profound differences between their mechanisms of 
threat recognition and threat response, however, the developmental origins of lym-
phocytes and myeloid cells are interlinked, and important aspects of their response 
mechanisms remain shared. It is notable that the chain of logic toward our current 
understanding of the immune defense system over the past 50 years has been driven by 
strongly posited models that have led to crucial discoveries, even though these models 
ended up being partly wrong. The predictive strength of these models and their success 
as guides to incisive experimental research have illuminated the limits of each model’s 
explanatory scope, beyond which another model needed to assume the lead. This brief 
review describes how a succession of distinct paradigms has helped to clarify a sophis-
ticated picture of immune cell generation and control.
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Overview
The vertebrate immune system provides a remarkable showcase of the differ-ent ways the genome can be used to specify cellular identity and to mediate 
cellular function. It is arguably the leading mammalian system in which gene regu-
lation programs that drive the acquisition of specific cell-type identities have been 
elucidated at the single cell level. More broadly for molecular genomics, the acti-
vation-induced gene expression pathways used in immune effector responses have 
provided textbook cases for fundamental elements of transcription factor assembly 
at enhancers (Rothenberg and Ward 1996; Thanos and Maniatis 1995); and immune 
system genes and gene clusters have provided key paradigms for the roles of long-
range genomic looping and distinctive intranuclear localization, principles that also 
turn out to govern enhancer-promoter interactions in general (Fuxa et al. 2004; 
Jhunjhunwala et al. 2008; Kosak et al. 2002). Finally, the developmental pathways 
of various immune cells from stem cells are offering dynamic and revealing models 
of how current transcription factor activities interlace with successive chromatin 
contexts, resulting from past regulatory experience, in order to guide lineage-spe-
cific cascades of gene expression (Heinz et al. 2010; Lin et al. 2010; McManus et 
al. 2011; Treiber et al. 2010; Vahedi et al. 2012; Weishaupt, Sigvardsson, and Attema 
2010; Wilson et al. 2010; Zhang et al. 2012). The genomic regulatory mechanisms 
that guide immune cell development from stem cells are now indeed recognized as 
offering useful parallels for stem-cell based modes of development in many other 
tissues. Thus, the vertebrate immune system now helps to reveal principles of ge-
nomic function and development in general.
However, the understanding of this whole system started with a unique, 
exceptional use of the genome that distinguishes two classes of immune cells, B and 
T lymphocytes, from all other cells in the body. These cells alone actively change 
their genomes by programmed somatic mutation as they mature. Most remarkably, 
the basic workings of this exceptional system and its rationale were inferred, 
through perceptive and far-reaching theoretical work, decades before they could 
be demonstrated and explained fully at molecular levels. This review tells the story 
of these insights, how far they have led, where they have had to be modified, and 
how this has ultimately led back to a broader picture of regulatory genomics of 
immune cell development that reintegrates lymphocyte function with the rest of 
the immune system.
The diverse migratory cells that interact to constitute the immune system are all 
cousins. Essentially, all immune cell types descend from hematopoietic stem cells, 
which are rare, broadly potent precursor cells that reside in the bone marrow. At a 
slow rate, a small percentage of these cells becomes activated to proliferate at any 
given time, yielding a massive burst of progeny cells. Some of the progeny regenerate 
the body’s supply of red blood cells and platelets for blood clotting, while others 
differentiate into a wide range of defensive cells. The defensive or immune-related 
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cells are especially diverse: they differ among each other in gene expression, migratory 
behavior, lifetime, ability to proliferate, and all other aspects of cell biology. They 
include some rapid-response cells with very short lifetimes (granulocytes), some 
potentially immortal cells that preserve extensive proliferative potential themselves 
(lymphocytes), and many types of cells in between (macrophages and dendritic 
cells), which specialize in detecting danger signals in the tissues of the organism and 
either killing an intruding organism outright or summoning help from other cells. 
To understand how the stem cell generates the right balance of different progeny 
cells with these distinct fates, two basic questions need to be addressed and given 
molecular definitions: (1) what are the fundamental elements of cellular identity 
that are relevant for function, and (2) how are the fundamental criteria of identity 
established in cells, at the levels of genomic and gene regulatory mechanisms?
The answers involve a rich literature of detailed molecular biology that continues 
to grow. But many of the basic issues relevant to the operation of the immune 
system are principles that have been brilliantly inferred, used to guide great runs 
of experimental success and further revelation, and then have been superseded by 
advances in understanding that they originally made possible. Key issues have been 
the roles of different modes of recognition specificity versus effector programming 
in immune cell functions, the recognition of foreign-ness versus the recognition of 
danger, and the kinds of logical syntax for multi-receptor signal processing that are 
needed to dictate an actual response.
Fundamental Criteria of Identity:  
Immune Function versus Immune Specificity
Immune cell types are distinguished by two criteria: (1) what genes they activate 
in response to a perceived “challenge,” and (2) what structures they need to detect 
in order to trigger these responses. The first criterion, immune effector function, 
is determined by genes that these cells keep poised for transcriptional activation, 
accessible for rapid transcription on demand but normally not expressed. Different 
immune cells are poised to activate different sets of effector genes and thus 
mediate different functions in a response. The second criterion, immune specificity, 
is determined by the structures that the cells express all the time, as cell surface 
receptors linked to signaling machinery. A central property of immune systems 
is that they are mosaics of nonequivalent cells that detect different potentially 
dangerous structures. The detection specificity of any individual cell depends on the 
biochemical details of the cell-surface receptors and the combination of different 
cell-surface receptors that the cell expresses. Immune cell identity is thus based on 
latent as well as constitutively expressed components.
All cells in the body, including immune cells, express genes only when the 
transcription factor combination in the cells is capable of activating transcription 
from those genes. There is an additional role for chromatin structure in making 
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certain genes more accessible to activation than others, based on a history of prior 
transcription factor action at sites that control those genes. But immune cells 
illustrate interesting principles for regulation of genomic function beyond the 
normal case, because their individuality emerges in ways that appear to cut across 
simple molecular models of gene expression control.
The cells’ functional identity combines mechanisms that define distinct cell types 
having predictable, reproducible behaviors, with a separate triggering dependence 
that controls deployment of their actions. The basis of this functional specificity is that 
the effector genes need to be turned on by a combination of transcription factors: 
subset-determining transcription factors that are stably, heritably expressed, but only 
in certain cells, together with acutely activation-dependent but broadly accessible 
transcription factors. The effector genes require activation by the intersection of 
these transcription factors—defining cell type and circumstance, respectively—but 
not by either class of transcription factors alone.
The cells’ recognition specificity, on the other hand, is defined by particular cell 
surface molecules that are constantly expressed once their expression is established. 
Individuality in recognition comes from expression of biochemically different cell-
surface proteins that act as receptors. Recognition specificity is overt, not latent, 
and can be evaluated clearly by analysis of the genes that the cell expresses all 
the time. However, multiple lymphocyte cell types have evolved ways to use the 
same complement of transcription factors to activate the expression of structurally 
distinct genes in different individual cells. To do this, they use a strategy that depends 
on a rather surprising degree of stochasticity in gene regulation. Large receptor-
encoding gene families become candidates for expression, but only one or a few 
coding sequences are actually expressed. Some immune cells go so far as to use 
a randomized somatic mutation strategy, both to increase the range of possible 
receptor coding sequences in play and to make one cell’s privileged expression of a 
given sequence permanent and heritable by its progeny.
Types of Immune Cells and Immune  
Response Strategies
The multiple types of immune cells are often lumped into two super-classes: 
“lymphoid” and “myeloid.” Lymphocytes are generally small, long-lived cells that 
amplify their long-term effectiveness against threats by using proliferation as part of 
their response mechanism. B cells and T cells are two major classes of lymphocytes. 
These cells can amplify their individual impacts on the system through proliferation, 
because their specificity is based on mechanisms that bequeath the same specificity 
to thousands of their clonal descendants if they are triggered. This strategy allows 
lymphocytes to mediate the “adaptive” immune response, in which the previous 
experience of the organism affects the spectrum of threats it is best prepared to 
counter in the future.
Immune Cell Identity
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Myeloid cells are primary mediators of the “innate” immune response. Myeloid 
cells for this discussion include macrophages, monocytes, neutrophilic granulocytes, 
and dendritic cells. They have long or short lifetimes depending on their class, 
but all normally exert complex defensive functions rapidly, without proliferating. 
Individual myeloid cells use conserved recognition receptors that have been selected 
through millions of years of evolution, and these are shared by many other myeloid 
cells in the population. The classes of receptors that are especially important for 
myeloid cells (such as Toll-like receptors and scavenger receptors) equip them to 
respond against whole categories of microbial products. Individual myeloid cells are 
armed with multiple receptors and can be activated through any of a wide range of 
stimuli. Myeloid cell function is one of the nonnegotiable requirements of viability 
for mammals and an ancient system shared with bilateria of all evolutionary clades.
For the last three decades of the 20th century, fascination with how lymphocytes 
achieve their individual specificities drew most attention to these cells and 
to the adaptive immune response in general. There was perceived to be a deep 
divide between the roles of innate and adaptive modes of response. However, for 
lymphocytes to work, we now understand that they partake of an elaborate response-
control machinery that is qualitatively very close to innate immune-cell function.
Early Conceptual Bases for Immune  
Response Dissection
Two paradigms have dominated understanding of the immune response for most of 
the last half-century.
Paradigm: Recognition of Self versus Non-Self
Insight into the nature of adaptive immune responses came in the mid-20th 
century from a convergence of cell biology with protein biochemistry. The major 
principles that emerged from these early studies applied to roles of both B and T cells 
in the immune system. A particularly important guiding principle that advanced the 
field was that lymphocytes distinguish self from non-self structures, and thus defend 
the organism by selectively attacking non-self.
It had long been known that adaptive immunity could be “raised” against 
microbes, to the extent that prior experience with a particular bacterium or virus 
could elicit a new barrier of immunity against reinfection. This turns out to be due 
to the proliferation of B and T cells that have receptors triggered by the microbes, 
in order to generate a long-term expansion of the population capable of attacking 
them, and to the B cells’ response of secreting high levels of antibodies against 
those microbial agents, which accumulate in the serum. Most of the pathogens 
one must neutralize in a typical lifetime are profoundly different life forms from 
oneself. Thus, for cells to focus on making a self versus non-self distinction could be 
viewed as surprisingly solipsistic. The threat of grafting tissue from another member 
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of one’s own species could hardly have been a strong evolutionary driving force for 
the vertebrate immune system. Nevertheless, lymphocytes indeed are distinctive 
in being able to recognize and respond against cells of another individual of the 
same species of organism, if they are genetically non-identical to self. The strategic 
genius of research focusing on this peculiar ability was that it allowed the problem 
of recognition to be considered separately from the problem of pathology. The self 
versus non-self distinction first enabled immune specificity to be defined in terms 
of genetics within a species; it also revealed the whole basis of T-cell recognition 
with substantial implications for T-cell development; it explained the importance of 
tolerance; and it was used to develop the central paradigm of lymphocyte function: 
the theory of clonal selection.
Paradigm: Developmentally Acquired Tolerance and Clonal Selection
The ability of lymphocytes to respond against nontoxic, normal organismal 
constituents simply because they happen to have a genotype subtly different from 
“self” raised the question of how the immune system avoids autoimmunity. This 
“horror autotoxicus” confronted the core problem of what immune cells recognize. 
The work of Owen in 1945 and Billingham, Brent, and Medawar in 1953 showed 
that tolerance—non-attack on a potential target—was developmentally conferred, 
based on experience, not on genetic identity. Any genotype of cell that immune 
cells were exposed to during their development could be tolerated, even if it was 
dissimilar to the host, whereas the same genetic difference encountered for the first 
time by mature cells could trigger rejection. How could organisms harbor immune 
systems that could react against anything else in the world, but not against structures 
that were encountered in the organism during development?
Clonal selection theory, developed long before anything was known about 
immune receptor structure, provided the key to understanding the whole adaptive 
type of immune response (Burnet 1957). F. Macfarlane Burnet, who created the 
clonal selection theory, had a background as a virologist. A great advance in virology 
in the mid-20th century had been the development of plaque assays, in which single 
virus particles can be enumerated accurately by their ability to infect single cells in a 
lawn of susceptible targets and form a “plaque” locally by replicating and spreading 
to neighboring cells. Each plaque represents the cells killed by a clone of viruses 
produced from a single initial particle, and plaque sizes provide a measure of how 
much the virus replicates during the assay since the initial infection. By creating a 
kind of plaque assay for immune cells, Burnet could see that individual lymphoid 
cells also proliferated while attacking non-self tissue. This suggested that differential 
proliferation could influence the system repertoire of immune responses themselves. 
Burnet’s great conceptual leap was then to assume that immune cells somehow 
must start out with diverse, clonally individual recognition specificities, and that 
those with specificities that allowed them to be triggered would expand in the 
population at the expense of those with other specificities. This readily provided a 
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way for different cell clones to become dominant in a population over the course of 
exposure to different challenges, through differential survival and proliferation. Even 
a rare cell in the initial population could generate disproportionately large numbers 
of progeny immune cells if its recognition specificity triggered stronger proliferation 
in a particular biological situation.
Clonal selection explained why the immune system can fight much more 
efficiently against a virus on second exposure than on initial exposure. It also 
elegantly explained how self versus non-self distinctions could be made, in a way 
that was consistent with the phenomenon of immunological tolerance. By clonal 
selection theory, all a diverse population needed to become self-tolerant was a 
mechanism such that during development, any cell with a specificity against self 
molecules could be triggered to die rather than live. The effector cell pool could 
thus be purged of dangerously self-reactive cells forever.
Thus, lymphocytes could be inferred to have highly diverse recognition 
specificities distributed among distinct, individualized clones; positive selection based 
on recognition specificity of mature functional cells during an immune response 
(memory); and a special kind of developmental pathway that included negative 
selection based on recognition specificity for immature cells (clonal deletion). In 
fact, these inferred features remain the distinguishing characteristics of lymphocytes 
as distinct from all other blood cells. Functional identity as a lymphocyte depends 
on deploying lineage-specific genomic mechanisms to provide immune receptor 
expression diversification, clonal specificity of receptor use, recognition-based 
proliferation control, and deletional mechanisms of tolerance during a particular 
developmental time window.
Clonally Unique Somatic Mutation and Selection 
Define Lymphocytes
The breakthrough in understanding of the adaptive immune system came from 
the recognition that immune receptor gene rearrangement in individual B and T 
lymphocytes provides the basis for clonal selection, by making individual lymphocytes 
unique in their specificities. This property further explains how selection at the 
cellular level results in a self-tolerant recognition repertoire at the population level.
Genomic Structural Definition of Receptors
Most of the cells that react against tissues from taxonomically similar but 
genetically distinct individuals are T cells. However, the receptors of B cells have 
features that made B-cell receptor structure easier to solve first. B cells respond 
to stimulation by secreting vast numbers of molecules that are versions of their 
own triggering receptor proteins, the immunoglobulins, and these soluble receptors 
circulate in the serum as antibodies. Protein structural analysis techniques were 
applied to solve basic antibody structures, and sequence analysis revealed that the 
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sequences of the proteins were very diverse (see Edelman 1973; Porter 1973). 
High diversity was concentrated toward one end of the immunoglobulin proteins, 
whereas the continuations of the same protein chains were often identical (Bennett 
et al. 1965). The diversity was functionally important, because the variable ends 
of the immunoglobulin molecules were the ends that could recognize and bind 
specific “antigen” targets. The basis of this extreme diversity became clearer as 
researchers took advantage of the fact that B cell–derived malignancies (multiple 
myeloma) in patients are derived from single rogue B-cell clones. Each myeloma 
produced homogeneous immunoglobulin proteins; however, different myelomas 
produced different immunoglobulins. By comparing the sequences of different 
myeloma-derived immunoglobulins, it emerged that the differences between them 
were highly patterned, with modest variability at the antigen-binding end overall, 
punctuated with three clusters of hypervariability (Wu and Kabat 1970).
How could the combination of extreme stability and extreme variability be 
achieved in different parts of the same protein chains (Dreyer and Bennett 1965)? 
There were arguments about whether this could be due to maintenance of a huge 
pool of possible immunoglobulin sequences in the genome, or whether it could be 
due to a special mutator mechanism. No one had described an example of a mutator 
that could yield the specific kind of variability seen in the immunoglobulin protein 
sequences. However, an answer emerged when molecular biology techniques 
finally advanced to the point where Hozumi and Tonegawa (1976), in a stunning 
result, showed that cells secreting antibodies actually have a discrete mutation, a 
rearrangement in their cellular DNA where it encodes the immunoglobulins. The 
rearrangement brings together DNA sequences that are separated in the germline 
and in all other cells in the body; only in B cells could they be juxtaposed to encode 
the immunoglobulin. Furthermore, a particular rearrangement was present only in 
the clonal cell population that produced a particular immunoglobulin, not in B cells 
universally. This work proved that lymphocyte-specific somatic mutation exists, and 
the breakthrough was rapidly extended by others (see, for example, Early et al. 1980; 
Seidman et al. 1978). The lymphocyte became the most interesting type of cell in 
the immune system and an urgent focus of investigation for the next 20 years.
Immune Receptor Gene Rearrangement Basis for Lymphocyte Exceptionalism
Lymphocytes thus differ from every other cell type in the body because they 
actually change their genomic inheritance during their development. Furthermore, 
each lymphocyte differs to a first approximation from every other one, because 
there is a huge range of different rearrangements that can give rise to valid but 
structurally different immune receptors. The rearrangement process not only creates 
diversity but also creates clonal specificity. This is because the variable parts of the 
receptor gene locus need to compete among themselves to be joined to a unique 
constant part, which not only encodes a crucial part of the protein but also is linked 
to the major transcriptional regulation machinery of the immunoglobulin locus as 
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a whole. Once this rearrangement has occurred, to a first approximation no other 
variable part can be expressed from the immunoglobulin genes on that chromosome. 
Thus the rearrangement process fulfills all the criteria for establishing a population 
on which clonal selection should work.
The revelation of the somatic mutation of antibody genes paved the way for 
discovering three novel enzymes that carry out this mutation, Rag1, Rag2, and 
terminal deoxynucleotidyl transferase (also called Dntt), and the genes that code for 
them (Kung et al. 1975; Oettinger et al. 1990; Schatz, Oettinger, and Baltimore 1989). 
As work proceeded into the 1990s, it became clear that both major subdivisions of 
lymphocytes use these enzymes to mutate different families of antibody-related genes 
(Komori et al. 1993; Shinkai et al. 1992). B cells use this recombination apparatus to 
assemble genes coding for immunoglobulins, which they both secrete as antibodies 
and use as cell-surface receptors; and T cells use this apparatus on distinct but related 
genes, encoding T-cell receptors (TCR), which they use as cell surface receptors 
only. The Rag1, Rag2, and Dntt genes coding for the somatic mutation enzymes 
were found to be expressed in B- and T-cell origin cell lines and all immature 
lymphocytes of both types, but not in any other blood cell type. In mammals, Rag1 
and Rag2 activities were shown to be essential for the cells to assemble full protein-
coding sequences from either immunoglobulin or T-cell receptor genes (Shinkai 
et al. 1992). Thus, lymphocyte development diverged from the development of all 
other blood cell types, at least to the extent that it uniquely provided the regulatory 
conditions needed to activate the Rag1, Rag2, and Dntt genes.
Transgenic Receptors, Allelic Exclusion, and Deletional Tolerance
Finding that every mature lymphocyte is somatically mutated had a significant 
impact on the ability to understand lymphocyte development. It meant that a 
transgenic approach could be used to alter lymphocyte specificity. Conceptual 
advances that emerged were early triumphs of the genomic modification strategy. 
The gene encoding a particular immune receptor could only be isolated 
from a clonal population of lymphocytes expressing that receptor. However, if a 
lymphocyte could be cloned, either by immortalizing it in malignant form or by 
growing it in favorable conditions, the genes coding for that cell’s receptor could 
be isolated and transferred to another cell. This would transfer deterministically the 
detailed recognition specificity of the initial cell to the new cell. An important flood 
of experiments followed, using transgenic mice in which a pre-rearranged TCR or 
immunoglobulin gene was inserted into the mouse germline and expressed in the 
precursors of T or B cells (see Melchers et al. 1994; von Boehmer, Teh, and Kisielow 
1989). These experiments were extremely successful at determining lymphocyte 
specificity in fine detail (Hogquist et al. 1994). But they also revealed something 
further: lymphocyte development itself is affected by the details of recognition 
specificity of the immune receptors the cells express. It became clear that the cells’ 
fate depends on their immunoglobulins or TCR.
Ellen V. Rothenberg Immune Cell Identity
214 Perspectives in Biology and Medicine
The cells’ developmental pathway includes checkpoints and feedbacks such that 
one—but only one—full receptor encoded by rearranged gene segments must be 
expressed. The loss of Rag1 or Rag2 not only blocked immunoglobulin and T-cell 
receptor expression, but also prevented development of the B and T cells themselves. 
However, if the developing cells were forced to express a particular immunoglobulin 
or T-cell receptor by transfection with a transgene, then they shut off rearrangement 
or expression of their endogenous genes so that only the transgene encoded their 
immune recognition receptors. Thus, essentially the whole population of B or T 
cells could be forced to express a single receptor, and the impact on the immune 
system was shown to be dramatic, depending on what the receptor recognized 
(Goodnow 1992; Kisielow et al. 1988b; Melchers et al. 1994; von Boehmer, Teh, and 
Kisielow 1989). If it strongly bound to a molecular structure that was also naturally 
present in the body of the mouse (“self”), then the overwhelming majority of 
developing lymphocytes could be caused to die before maturation. Certain non-
transgenic TCRs in the immature population could also be systematically eliminated, 
in elegant agreement with models imagined decades earlier by Burnet (Kappler, 
Roehm, and Marrack 1987).
Positive Selection and Fate Determination
In developing T cells, TCR specificity determines not only survival of the cells 
but also the direction of their specialization to “killer” or “helper” functional types 
(see Kaye et al. 1989; Teh et al. 1988). This process is guided by the interaction of 
the T-cell receptor with one of two alternative kinds of cell surface molecules called 
major histocompatibility complex (MHC) molecules, which are special recognition 
targets for T cells. MHC molecules are encoded by genes that happen to exist in 
multiple allelic variants in mammalian populations, and their job is to be expressed 
by non-T cells as a presentation armature for small fragments of diverse proteins, 
either from normal or diseased cells. TCR molecules each recognize the complex 
of an MHC molecule with some particular peptide fragments on the surfaces 
of antigen presenting cells, often dendritic cells. It is because they are biased to 
recognize MHC molecules as part of their triggering ligands, and because MHC 
molecules are so polymorphic within a species, that T cells tend to detect rapidly 
whether they are interacting with cells that are from self or non-self.
T-cell development is restricted to the thymus, an organ where the cells can 
be sequestered until their newly expressed T-cell receptors have been tested for 
appropriate recognition specificity and directed to the correct differentiation 
pathway. The thymus was indeed found to dictate the definition of “self.” If the 
T-cell receptor bound too well to structures expressed naturally within the thymus, 
the developing T cell would be purged. However, T cells escaping this purge could 
emerge from the thymus, primed for potent attack on a virally infected cell, an alien 
cell, or any non-self structure bound to a cell that they might be able to recognize.
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Most interestingly, the successfully developing T cells were found to direct their 
differentiation pathway in the thymus to different functional end states, depending 
on whether their TCR reacted better with one or another type of MHC molecule 
(Kaye et al. 1989; Kisielow et al. 1988a; Teh et al. 1988; von Boehmer et al. 1989). 
The intensity and kinetic profiles of the signaling pathways activated by TCR 
engagement turn out to diverge depending on whether the cell’s TCR reacts 
with “MHC class I” or “MHC class II,” and the cell responds to this difference in 
signaling by developing into a potential killer T cell or a potential “helper” T cell 
(growth factor source), respectively (Singer, Adoro, and Park 2008). These are highly 
coherent and mutually exclusive differentiation programs, and this choice is one of 
a series of major developmental branchpoints available for T cells (Carpenter and 
Bosselut 2010; Naito and Taniuchi 2010). Normally, the difference between TCRs 
able to react with one or the other MHC type can be very small, just a few amino 
acid differences. Thus, completely stochastic features of the TCR somatic mutation 
process generate outcomes that determine whether the cell will be enrolled in one 
or the other predefined T-cell differentiation option.
Note, however, that through this phenomenon a chink had appeared in the armor 
of the self versus non-self distinction as a fundamental principle of T-cell function. 
The only way to determine whether an immature T cell’s TCR reacted with one 
or the other MHC type would be for this interaction to occur and transmit a signal. 
Thus, some reaction with an intrathymically expressed MHC molecule was essential 
to enable any T cell to mature. Indeed, cells with TCR that did not interact with 
self MHC at all died in the thymus without maturation. This meant that despite 
elimination of cells that bind strongly to self antigens, all surviving cells had to have 
at least a weak reactivity against self MHC (Bevan, Hogquist, and Jameson 1994; 
Hogquist et al. 1994). Self versus non-self recognition thus began to slip from an 
absolute distinction toward a quantitative aspect of receptor affinity.
Clonal Diversity and Selection Are Incomplete as 
Accounts of T Cell Function
The successes of the transgenic receptor imposition strategy made it possible to 
create mice with designer B or T cell populations of known recognition specificity. 
This made it possible to hold specificity constant and begin to explore other 
mechanisms that affect the outcome of immune responses. Interestingly, this quickly 
revealed four areas where population receptor specificity fell short as a predictor of 
actual immune response outcome: the role of co-stimulation, the role of cytokines, 
the failure to explain pregnancy, and evidence for non-deletional mechanisms of 
tolerance.
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Need for Co-Stimulation to Explain T-Cell Triggering
By 1990, it appeared that the questions of adaptive immunity had been answered 
by the identification of these mechanisms for the diversification and clonal selection 
of B- and T-cell receptors. Deletional tolerance confirmed the predictions of Burnet 
and appeared to have resolved how self–non-self distinction worked. However, the 
very power of these results provided the wedge to pry open another set of questions 
for which B- and T-cell receptor specificity was not the answer. By experimentally 
imposing the same immune receptor with a known specificity on all the cells in a 
population, it became possible to see that the main B-cell receptor or T-cell receptor 
is not sufficient to determine entirely when and how a B cell or T cell will act in 
an immune response. In fact, such experiments showed that the unique feature of B 
and T lymphocytes was only one component of a multi-receptor triggering system 
that combinatorially determined how the cells would respond.
The power of a single transgene product enforced on a population as its sole TCR 
was most dramatic for T cells, because they have only one window of developmental 
time when they can determine their receptor specificity. TCR-transgenic T-cell 
populations developing in vivo or in thymic organ cultures could be tested for 
their responses to defined peptide variants of the cognate antigen of the original 
TCR. It emerged that even ideal TCR stimulation could not drive cells to a full 
effector response unless additional cell surface receptors with qualitatively different 
ligands were also engaged, including molecules called co-stimulatory receptors. The 
suggestion that co-stimulatory receptors might be important dated back to 1970, 
long before immunoglobulin or TCR genes had been cloned, when Bretscher and 
Cohn had extrapolated from a very primitive experimental system to postulate that 
lymphocytes need two signals, not just the antigen receptor signal, in order to be 
triggered to respond. There are now known to be several families of co-stimulatory 
receptors, different ones used by B and T cells, but each of them consisting of 
invariant cell surface molecules that recognize invariant transmembrane cell surface 
molecules on antigen presenting or cooperating cells, usually dendritic cells or the 
complementary type of lymphocyte (Croft 2009; Rickert, Jellusova, and Miletic 
2011; Sharpe and Freeman 2002). Co-stimulatory receptors on T cells are crucial to 
engage, alongside the TCR, in order to push T cells over the threshold of full effector 
response. In fact, engagement of the TCR without this kind of co-stimulatory signal 
can lead to a state of cellular paralysis, called anergy (Mueller, Jenkins, and Schwartz 
1989).
Instructive Actions of Cytokines: Same Antigen Receptor, Different Function
Another class of auxiliary stimulating molecule consists of receptors for soluble 
protein hormones secreted by other immune cells, called cytokines. Cytokines are 
among the effector molecules that T cells secrete when they are fully activated, and 
they work both on the secreting cell and on the neighboring cells. They strongly 
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influence myeloid cells as well as other lymphocytes. Cytokine receptors had already 
been shown to be indispensable for lymphocyte clonal proliferation. In fact, the 
reason lymphocytes proliferate so extensively in response to antigen signaling is 
the fact that both cytokines with growth factor activity and the receptors for those 
growth factors are transcriptionally activated by antigen recognition, creating a 
locally intense positive feedback (Smith 1988). The most co-stimulation–dependent 
response first recognized for T cells was the control of activating a strongly growth-
promoting cytokine gene, Il2 (Powell et al. 1998). However, other cytokines were 
soon recognized to do more than promote growth: they could also promote 
differentiation along distinct functional pathways (O’Shea and Paul 2010; Zhou, 
Chong, and Littman 2009; Zhu, Yamane, and Paul 2010). Different effector classes 
of helper T cells are produced when T cells respond to antigen in the presence of 
different cytokines.
Identification of these elements made it possible to prove that the fates of 
individual T-cell progeny could diverge functionally even if their TCR specificities 
were identical (Hsieh et al. 1992; Sad and Mosmann 1994). Single T cells could 
be grown up to clones in culture, then split to proliferate under different culture 
conditions, or TCR-transgenic T cells could be stimulated with the same known 
antigen target, but in different cytokines. Despite expression of the same TCR and 
stimulation with the same TCR ligand, different descendants could predictably 
differentiate to opposite kinds of functional effectors if they were grown in the 
presence of differently polarizing cytokines. Thus, even for T cells, identity could 
not be defined by TCR alone.
Incompleteness of Paradigm: Failure to Explain Tolerance in Real Life
The presumed solution to self versus non-self discrimination itself was also 
challenged by fresh perspectives and results, forcing a return to the problem of 
tolerance. One obvious case needing explanation had remained hidden in plain 
sight for years. Sadly, it was not until a number of female immunologists reached 
prominence in the field that the significance of mammalian pregnancy was 
recognized. Evidently the fetus is non-self with respect to the mother. It had been 
assumed that the fetus is protected by an immunological “barrier,” but the maternal 
immune system does encounter fetal cells immunologically. Women who have had 
multiple babies were long known to harbor antibodies that specifically recognize 
paternally inherited antigens expressed by their children, and later it was possible 
to show that fetal cells are actually circulating in maternal blood during normal 
pregnancy, and vice versa (see Mold and McCune 2012). Yet the survival of every 
mammalian species depends on the maternal ability to protect rather than reject the 
fetus. Thus, it is not the “non-self” status of the fetus, but the conditions in which 
maternal–fetal cell interactions occur that determine whether immune tolerance 
or attack should occur. A T cell that developed and passed selection in a woman’s 
thymus during her virginity must have a way to be prevented from attacking the 
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baby she conceives later, despite its expression of molecules inherited from its 
genetically distinct father.
In fact, all tolerance involves continued circumstantial as well as structurally 
inherited control, as has further been reinforced by an alarming medical trend which 
demonstrates the contrapositive case. As infectious disease has declined in advanced 
societies, the incidence of true autoimmune disease has skyrocketed. Intense 
investigation of the causes has confirmed that deletional tolerance is not enough 
to guarantee full self-tolerance: even true self antigens are subject to immune attack 
unless restraint mechanisms are actively maintained. Furthermore, a fetus is not the 
only non-self structure that the immune system must forbear to attack. Unleashing 
a maximally inflammatory attack on common gut bacteria creates unacceptable 
collateral damage and serious pathology. Even when non-self is all around, the 
response must sometimes be blocked.
Ironically, this understanding had long been foreshadowed by earlier studies, 
going back to Bretscher and Cohn. But the physiological significance became much 
clearer when the phenomena of co-stimulation and response paralysis were viewed 
through the lenses provided by two important models: the “pathogen associated 
molecular pattern” idea of Medzhitov and Janeway (Janeway 1989; Janeway and 
Medzhitov 2002), and the “danger model” of Polly Matzinger (1994, 2002). These 
broad, integrative models helped to validate research that looked beyond TCR 
and immunoglobulin specificity, putting the emphasis instead on information 
conveyed to the cells by less-glamorous, more “innate-like” invariant receptors for 
environmental cues.
Mechanisms of Immune Response Restraint
Two major mechanisms are now seen to limit immune responses even when the 
TCR recognizes its target antigen. It is now clear that lymphocytes do distinguish 
antigen recognition in a situation rife with pathogens, traumatic cell death, or other 
danger, from antigen recognition in a situation of normal growth and development. 
To do this, they have to use their co-stimulatory receptors to detect contextual 
cues from the affected tissue itself and from local myeloid cells, acting as antigen-
presenting cells. This works because the antigen-presenting cells in turn, and to some 
extent the lymphocytes themselves, use a different class of receptors called Toll-like 
receptors to detect whether any of diverse classes of microbial products are present. 
They also use additional receptors to detect signs of inflammation, preformed 
antigen-antibody complexes, and debris from neighboring cell death (Macagno 
et al. 2007). It is the signaling from these environment-monitoring receptors that 
determines whether or not the antigen-presenting cells also present co-stimulatory 
ligands. As an alternative, tissues and antigen-presenting cells alike have the option 
of expressing co-stimulatory receptor antagonists or inhibitory receptor signaling 
molecules rather than co-stimulators, and these antagonists veto immune responses 
(Chambers and Allison 1999; Keir et al. 2008; Sharpe and Freeman 2002). When 
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expressed, co-stimulation antagonists can play a locally overwhelming role in 
determining whether a tissue will or will not be subject to attack, irrespective of self 
or non-self status and whether or not it is healthy, with immense consequences for 
systemic tolerance, autoimmunity, and cancer immunotherapy (Reynoso et al. 2009; 
Sharma and Allison 2015).
A second mechanism of tolerance has drawn massive recent interest: this is the 
discovery of a class of helper-like T cells that react to their environments not by 
activating effector function, but rather by exerting positive restraint on neighboring 
T cells (regulatory T cells, or T regs) (Fontenot and Rudensky 2005; Walker and 
Abbas 2002; Wing and Sakaguchi 2010). Some of these cells are autoreactive T 
cells that have escaped deletion in the thymus in order to become antagonists of 
the responses of other T cells. Others are programmed for this policing role locally, 
when they respond to antigen in the context of certain environments. The ability 
to interpret TCR engagement signals differently depending on the context of 
environmental conditions, including the engagement of distinct cytokine receptors, 
is fundamental to the generation of these important cells.
Thus, the response that T-cell populations actually make can only be determined 
by the logical combination of signals from the antigen-specific receptor and from 
all the receptors for these additional circumstantial cues.
Alternatives to Clonal Selection as Ways  
to Direct Immune Responses
The requirement for signals other than those from antigen-specific receptors 
to determine T-cell responses should not have been a complete surprise. In fact, 
some of the most essential components of the immune defense system had long 
been known to play highly effective roles in host defense without undergoing any 
immune receptor gene rearrangement and without requiring clonal selection at all. 
The Myeloid Counterexample: Development and Function
As the roles of cytokines in shaping immune response became increasingly 
prominent, it also became clear that many of the most potent cytokines were being 
produced not by T cells, but by the antigen-presenting cells with which they interact, 
especially dendritic cells. A major step forward came with the identification of 
Toll-like receptors, evolutionarily ancient and highly conserved, of which different 
members detect different classes of bacterial or viral “pattern-identifying” molecules 
(Medzhitov, Preston-Hurlburt, and Janeway 1997). In dendritic cells, macrophages 
and monocytes, the signal transduction apparatus downstream from Toll-like 
receptors was revealed to be a distinct response system parallel to the system activated 
by immunoglobulins and TCR on lymphocytes. Myeloid cells, it was realized, use 
these recognition systems to trigger expression of the co-stimulatory molecules and 
production of the particular cytokines that go on to direct the choice of effector 
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differentiation that is followed by the T cells they interact with (Macagno et al. 
2007). Suddenly, the antigen-presenting cells, despite their lack of clonally diverse 
receptors, were appearing to have the upper hand in an immune response.
One feature of myeloid cells that had to be accounted for was the way cells with 
multiple types of triggering receptors calculate the intensity, quality, and duration 
of their responses. There was no possibility of considering them simply cells that 
were either “on” or “off,” since the destructive power with which inflammatory 
macrophages and granulocytes are armed is sufficient to cause immense tissue 
damage if it is not kept under control. Human inflammatory diseases show the 
consequences of even limited, local deregulation. Thinking about myeloid cell 
responses revealed the simplifications at the heart of the lymphocyte clonal selection 
model, since clonal selection a priori requires no response modulation at the single 
cell level—only a question of how many cells in the population have a receptor 
that allows them to be triggered by some antigen to go through one more round 
of cell division. Myeloid cell responses, in contrast, only make sense in a context 
of quantitatively modulated signaling and combinatorial signal processing on the 
way to the transcriptional regulatory apparatus. As already noted, while this view of 
signaling is inescapable for myeloid cells, it turns out to be needed to explain T-cell 
responses as well.
“Innate” Lymphocytes: A Threat to Lymphocyte Exceptionalism?
Lymphocytes had seemed special with respect to the rest of the hematopoietic 
system for at least two decades, partly because their clonally diverse immune receptor 
gene rearrangements appeared to dominate their roles in the body, and partly 
because their development appeared to emerge from a class of dedicated common 
lymphoid precursors that separated from the precursors of other blood cells at a very 
early stage. The discovery that T-cell function could be so strongly modulated by 
combinatorial signaling from receptors as structurally invariant as those that myeloid 
cells might use did not immediately affect this perceived exceptionalism. However, 
new classes of lymphocytes were discovered that posed a challenge to this cell 
classification hierarchy, and to the idea that all mature-cell properties are accessible 
exclusively according to a fixed developmental hierarchy.
Natural killer cells were recognized since the 1980s to be an exception among 
lymphocytes, in that they did not seem to follow conventional rules of self versus 
non-self distinction . When two different inbred parental types are crossed, both 
parental genotypes in the hybrid progeny are components of “self”—and by 
conventional T-cell recognition rules, these hybrids should be tolerant of both 
parental types. However, in grafts involving certain cell types, it was found that 
hybrids had a way to reject the parental cells. The reason was not because the graft 
cells included a non-self determinant, but because they were lacking in one of 
the hybrid’s determinants of self. There must be a system, therefore, that acted as a 
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mirror image of T-cell specificity: one that defined tissues as worthy of tolerance not 
by what they lacked—non-self—but rather by what they positively expressed—a 
full quorum of relevant self molecules.
This system was found to consist of natural killer cells, closely related to killer 
T cells in function but completely unrelated in mechanisms of target recognition 
(Yokoyama 1995). They are activated to kill by abnormalities in a target cell’s surface, 
but inhibited by contact with self MHC. Their demand for positive recognition 
of self molecules in order to spare a potential target cell from killing creates a key 
backup system, to eliminate cancers and virus infected cells that have attempted 
to evade killer T-cell attack by down-regulating MHC. The natural killer mode of 
recognition has also proven to be evolutionarily ancient, shared with nonvertebrate 
chordates. However, the oddness of NK cells lies in how one must think about their 
developmental programming.
Natural killer cells combine a completely non-TCR like, non-Ig like, Rag1/
Rag2-independent mechanism for recognizing their targets, and a non-thymic 
developmental pathway, together with an effector system that appears to be duplicated 
from the effector system of a particular subset of mature T cells, the effector killer 
T cells (Ramirez and Kee 2010). The hierarchy of relatedness among lymphocyte 
cell types defined by Rag1/Rag2-dependent recognition machinery would place B 
and T cells close together, with NK cells as outliers. Yet this is completely different 
from the hierarchy defined by the battery of co-regulated response genes, in which 
NK cells are much closer to T cells than B cells or myeloid cells. By this criterion 
NK cells even appear to be nested with a particular mature T-cell effector subset, 
the killer T cells, at a branchpoint well inside of the T-cell developmental hierarchy. 
This surprise provided an early glimpse that lymphoid effector function and 
lymphoid recognition machinery are controlled in separate modular ways, and may 
be deployed independently in different lineages of cells.
Very recently, it has been found that cells corresponding to natural helpers 
(innate lymphoid cells) also exist (see Constantinides et al. 2014; Diefenbach et al. 
2014; Di Santo 2014; Hazenberg and Spits 2014). These cells are subjects of intense 
investigation, and little is known yet about the nature of their triggering specificities, 
except that they lack TCR. However, they are clearly able to deploy helper T-cell 
like functions when stimulated through a TCR-independent triggering pathway. 
These cells are found in fat, intestine, and other tissues and appear to act as sentinels 
of local damage. Like helper T cells, there are three subtypes of innate lymphoid 
cells with effector programs that are distinct and stable, and correspond almost 
perfectly to the effector programs of three subtypes of helper T cells. As for 
NK cells and killer  T cells, there is extensive sharing of regulatory gene expression 
as well as effector gene expression between these innate lymphoid cells and the 
corresponding subsets of helper T cells as well (De Obaldia and Bhandoola 2015). 
Thus, whole gene regulatory network circuits controlling effector function can be 
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deployed either within the T-cell program or in a parallel, non-T-cell program. The 
cases of NK and innate lymphoid cells demonstrate that all T-cell functions are 
modular and controllable independently of TCR expression machinery.
This modularity has been reinforced by the discovery that even certain kinds of 
T cells may actually dispense with the need for clonal diversity and clonal selection. 
Early fetal T cells and several classes of variant T cells called “innate-like gd cells,” “NK 
T cells,” or “MAIT cells” do undergo Rag-mediated programmed rearrangement of 
the TCR genes and develop in the thymus (Alonzo and Sant’Angelo 2011; Chandra 
and Kronenberg 2015; Havran and Allison 1990; Kreslavsky et al. 2010). However, 
they use only a tiny fraction of the potential diversity of TCR gene segments for 
rearrangement, limit or eliminate other mutational mechanisms, and thus constitute 
a population in which many independent clones express similar or identical TCR. 
These cells, like NK cells, can become equipped with particular biased effector 
response capabilities similar to those of conventional effector T-cell subsets, and they 
do contribute to system health (Lee et al. 2013). With so many clones expressing 
near-identical receptor specificities, they can ensure a response against specific 
targets, but selective proliferation yielding immunological memory is not evident. 
These are T cells with an innate-immune-like modus operandi.
Evolution of Lymphocytes: Separate Recognition and Response Modules
The precedents set by NK cells and “innate-like” T cells have been extremely 
useful to adjust expectations in looking across long evolutionary distances for clues 
to the origin of lymphocytes. Lymphocytes themselves appear to be a vertebrate 
innovation. Immunoglobulin and TCR genes, as well as MHC molecules, seem to 
be absent in the genomes of any organisms more divergent from mammals than 
jawed vertebrates. Rag-type recombinases are present in sea urchins, but their target 
sequences are unknown; they may or may not be used to recombine immune-cell 
receptors in those animals. Thus for many years a prominent theory was that an 
immunological Big Bang occurred at the base of the jawed vertebrate radiation. 
However, in the past decade dramatic advances have occurred in the characterization 
of the immune systems of jawless vertebrates, lampreys and hagfish.
In these animals, there are lymphocytes which use completely different families 
of molecules for recognition than immunoglobulin superfamily molecules—yet 
they use them in clonally restricted expression (Pancer et al. 2005). They do not 
use Rag1/Rag2 recombinases to mutate these genes—but they do assemble the 
coding sequences by clonally diverse, somatic recombinational mechanisms, using 
a different recombination system (Alder et al. 2005). They do not have a thymus 
as such—but they have T and B cells, where the B cells secrete a version of their 
receptors as effector molecules while the T cells do not, and they have a thymus 
equivalent tissue, distributed in patches of tissue at the tips of their gills (Bajoghli 
et al. 2011; Guo et al. 2009). The lampreys’ T cells are distinguished from their B 
cells by effector gene and transcription factor expression. Although none of the 
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recognition molecules that they use for T-cell function are shared with mammalian 
T cells, they do share almost all of the key transcription factors. The underlying 
program for adaptive immunity, the clonal selection strategy, and even the broad 
distinctions between T and B cells are thus considerably older than the molecules 
used for the antigen-specific recognition functions of mammalian T and B cells. 
Lymphocyte biology as a whole is thus defined in evolution in a modular way, 
within which the antigen receptor genes and their clonal diversification mechanism 
constitute only one, potentially changeable module.
Reconnecting the Innate and Adaptive Branches of 
the Immune System
With increasing interest in myeloid cells as antigen-presenting cells and immune 
response regulators, the development of myeloid cells became clearer as well, and 
their diversification into a rich array of subtypes. Myeloid cells had been thought 
to be closely related to red blood cells and the megakaryocytes that give rise to 
blood-clotting platelets, with lymphocytes split out as a profoundly distinct branch 
of hematopoiesis (Kondo, Weissman, and Akashi 1997), but evidence began to 
accumulate to challenge this relationship hierarchy. Lymphocyte precursors and 
myeloid cell precursors were found to share a key transcription factor, PU.1, and 
precursors that had lost access to red blood cell potential but retained myeloid and 
lymphoid potential were found among the multipotent blood cell differentiation 
intermediates (Adolfsson et al. 2005; Arinobu et al. 2007; Nutt et al. 2005). Early 
lymphocyte precursors were found that could transdifferentiate easily into myeloid 
cells, probably by exploiting a regulatory “bridge” provided by PU.1 activity, until 
a later stage in lymphocyte commitment (Bell and Bhandoola 2008; Wada et al. 
2008; Yui, Feng, and Rothenberg 2010). The results with T-cell precursors were 
particularly clear—normal T-cell precursors could still give rise to dendritic cells or 
even granulocytes and macrophages as alternatives, at least one full stage later into 
the T-cell pathway than they could still give rise to B cells. Such results indicated 
that the lymphoid programs of differentiation shared deep roots with the myeloid 
program. In these terms, the whole immune/defense system, innate and adaptive, 
could be seen as a multiply branched but ultimately related multicellular entity.
Conclusion
Self versus non-self discrimination and clonal selection have been hugely important 
guiding paradigms for the development of immunology in the last 60 years. Clonal 
diversification by somatic mutation of receptor genes has been an extraordinary 
tool for discovery of the inner workings of the immune response. However, the 
system that actually defends us from disease uses these mechanisms for just a modest 
part of its function. What has been revealed is a set of complementary strategies 
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for specialist contributions to host defense, one in which not only forcefulness of 
response but also judiciousness of response in terms of specificity and dynamic 
regulation are crucial components.
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